Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,258 public trials 1,193 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors

NCT03319459

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +63 more
Locations
  • UCSD Moores Cancer Center San Diego, California, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • The Ohio State University James Cancer Hospital Columbus, Ohio, United States
  • Baylor Scott & White Research Institute Dallas, Texas, United States
View Trial Details
Completed

Pegzilarginase and Pembrolizumab for Extensive Disease Small Cell Lung Cancer

NCT03371979

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • University of Alabama, Mitchell Cancer Institute Mobile, Alabama, United States
  • University of Colorado Aurora, Colorado, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Mid Florida Hematology and Oncology Centers Orange City, Florida, United States
View all 22 locations
View Trial Details
Completed

Study of Participants With Advanced Non-Small Cell Lung Cancer

NCT00948675

Conditions
Advanced Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Scottsdale, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tucson, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mission Hills, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aventura, Florida, United States
View all 45 locations
View Trial Details
Completed

Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC

NCT01757288

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Rochester Rochester, New York, United States
  • UPMC Cancer Center Pittsburgh, Pennsylvania, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Completed

Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer

NCT02566993

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • St Jude Hospital Yorba Linda dba St Joseph Heritage Healthcare Fullerton, California, United States
  • Loma Linda University Medica! Center Loma Linda, California, United States
View all 160 locations
View Trial Details

Related conditions